Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ)
CNY 16.77
(1.95%)
CNY 16.77
(1.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.53 Billion | 3.5 Billion | 3.13 Billion | 2.96 Billion | 2.79 Billion | 3 Billion |
| Cost of Revenue | 2.07 Billion | 1.88 Billion | 1.48 Billion | 1.24 Billion | 1.16 Billion | 1.5 Billion |
| Gross Profit | 1.46 Billion | 1.62 Billion | 1.65 Billion | 1.72 Billion | 1.63 Billion | 1.5 Billion |
| Operating Expenses | 1.23 Billion | 1.21 Billion | 1.37 Billion | 1.34 Billion | 1.15 Billion | 975.92 Million |
| Selling, General and Administrative Expenses | 1.03 Billion | 723.98 Million | 918.73 Million | 895.09 Million | 668.91 Million | 539.49 Million |
| Research and Development Expenses | 187.57 Million | 171.1 Million | 178.33 Million | 191.9 Million | 263.91 Million | 218.1 Million |
| Other Expenses | 13.73 Million | -7.81 Million | -13.49 Million | -10.56 Million | 159.83 Million | 2.18 Million |
| Cost and Expenses | 3.31 Billion | 3.09 Billion | 2.85 Billion | 2.58 Billion | 2.31 Billion | 2.47 Billion |
| Operating Income | 225.84 Million | 353.77 Million | 210.04 Million | -414.81 Million | 155.32 Million | 367.91 Million |
| Interest Expense | 24.92 Million | 26.82 Million | 27.03 Million | 23.31 Million | 18.81 Million | 15.08 Million |
| Income Tax Expense | 32.09 Million | 60.09 Million | 73.46 Million | 55.29 Million | 101.14 Million | 87.78 Million |
| Earnings before Tax | 225.4 Million | 345.96 Million | 196.55 Million | -425.38 Million | 315.15 Million | 370.09 Million |
| Net Income | 174.7 Million | 273.36 Million | 107.98 Million | -488.84 Million | 203.28 Million | 263.86 Million |
| Earnings Per Share Basic | 0.46 | 0.71 | 0.28 | -1.26 | 0.52 | 0.67 |
| Earnings Per Share Diluted | 0.46 | 0.71 | 0.28 | -1.26 | 0.52 | 0.67 |
| Weighted Average Shares Outstanding | 383.87 Million | 385.02 Million | 385.65 Million | 387.97 Million | 390.93 Million | 393.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 383.87 Million | 385.02 Million | 385.65 Million | 387.97 Million | 390.93 Million | 393.82 Million |
| Gross Margin | 0.41 | 0.46 | 0.53 | 0.58 | 0.58 | 0.50 |
| EBIT Margin | 0.16 | 0.19 | 0.16 | 0.19 | 0.30 | 0.24 |
| Profit Margin | 0.05 | 0.08 | 0.03 | -0.17 | 0.07 | 0.09 |
| EBITDA | 564.01 Million | 628.55 Million | 447.61 Million | -185.9 Million | 524.47 Million | 561.08 Million |
| Earnings Before Tax Margin | 0.06 | 0.10 | 0.07 | -0.14 | 0.06 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 756.74 Million | 817.1 Million | 921.27 Million | 969.55 Million | 3.53 Billion | 863.45 Million |
| Cost of Revenue | 461.6 Million | 556.37 Million | 517.1 Million | 509.88 Million | 1.99 Billion | 511.51 Million |
| Gross Profit | 295.13 Million | 260.72 Million | 404.17 Million | 459.67 Million | 1.54 Billion | 351.94 Million |
| Operating Expenses | 258.03 Million | 221.93 Million | 295.41 Million | 378.42 Million | 1.25 Billion | 296.57 Million |
| Selling, General and Administrative Expenses | 388.79 Million | 179.53 Million | 257.63 Million | 4.97 Million | - | 397.69 Million |
| Research and Development Expenses | 40.97 Million | 35.26 Million | 37.71 Million | 62.88 Million | - | 45.61 Million |
| Other Expenses | -171.73 Million | -7.13 Million | -63.98 Thousand | -1.22 Million | -441.67 Thousand | -733.12 Thousand |
| Cost and Expenses | 719.63 Million | 778.31 Million | 812.51 Million | 888.31 Million | 3.24 Billion | 808.09 Million |
| Operating Income | 32.49 Million | 38.78 Million | 108.76 Million | 50.33 Million | 225.84 Million | 41.34 Million |
| Interest Expense | 4.47 Million | 5.21 Million | 4.85 Million | 5.73 Million | 24.92 Million | 5.72 Million |
| Income Tax Expense | 9.8 Million | -1.35 Million | 26.39 Million | 2.45 Million | 32.09 Million | 4.72 Million |
| Earnings before Tax | 32.94 Million | 48.61 Million | 115.87 Million | 49.1 Million | 225.4 Million | 40.6 Million |
| Net Income | 20.46 Million | 47.62 Million | 82.97 Million | 42.22 Million | 174.7 Million | 30.77 Million |
| Earnings Per Share Basic | 0.05 | 0.13 | 0.22 | 0.11 | - | 0.08 |
| Earnings Per Share Diluted | 0.05 | 0.13 | 0.22 | 0.11 | - | 0.08 |
| Weighted Average Shares Outstanding | 379.33 Million | 379.33 Million | 383.87 Million | 383.87 Million | 383.87 Million | 382.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 379.33 Million | 379.33 Million | 383.87 Million | 383.87 Million | 383.87 Million | 382.83 Million |
| Gross Margin | 0.39 | 0.32 | 0.44 | 0.47 | 0.44 | 0.41 |
| EBIT Margin | 0.05 | 0.15 | 0.13 | 0.09 | - | 0.07 |
| Profit Margin | 0.03 | 0.06 | 0.09 | 0.04 | 0.05 | 0.04 |
| EBITDA | 37.41 Million | 120.25 Million | 117.82 Million | 85.42 Million | - | 57.75 Million |
| Earnings Before Tax Margin | 0.04 | 0.05 | 0.12 | 0.05 | 0.06 | 0.05 |
CCOEY
TDS
TIAIY
GLRI
910322
MLPT